Athenex Announces Recent Product Launches in Commercial Business
August 01, 2017 08:00 ET | Athenex, Inc.
BUFFALO, N.Y., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex, Inc.將於2017年8月14日公佈2017年第2季度財報
July 31, 2017 10:23 ET | Athenex, Inc.
紐約水牛城, July 31, 2017 (GLOBE NEWSWIRE) -- 致力於發掘、研發和商業化癌症新療法的全球生物醫藥公司Athenex, Inc.(Nasdaq: ATNX)今天宣佈,將在2017年8月14日市場開盤前發佈2017年第2季度的財報。公司將於2017年8月14日星期一美國東部時間早上9點舉行視訊會議及網路廣播。 ...
Athenex, Inc. to Report Second Quarter 2017 Earnings Results on August 14, 2017
July 31, 2017 08:00 ET | Athenex, Inc.
BUFFALO, N.Y., July 31, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex, Inc. 宣佈獲得紐約州對位於敦克爾克藥廠的稅收優惠
July 28, 2017 00:35 ET | Athenex, Inc.
紐約州水牛城, July 28, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc.(Nasdaq: ATNX),一家致力於發掘、研發和商業化新型治療癌症的全球生物醫藥公司,今天宣佈其位於紐約敦克爾克鎮、使用最先進技術的製藥廠已經取得紐約州與當地的稅收優惠,該製藥廠價值2.08億美元。 在學托擴縣工業發展局(Chautauqua County Industrial...
Athenex, Inc. Announces Approval of Tax Incentives from State of New York for the Dunkirk Facility
July 27, 2017 08:00 ET | Athenex, Inc.
BUFFALO, N.Y., July 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex, Inc. 宣佈Oraxol搭配Ramucirumab聯合療法治療胃癌開始納入第1b期臨床試驗患者
July 19, 2017 23:48 ET | Athenex, Inc.
紐約州水牛城, July 20, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), 一家致力於開發、發展與商業化癌症治療新療法的全球性生物醫藥公司,今日宣布其Oraxol搭配ramucirumab聯合療法治療胃癌的全球第1b期臨床試驗最近開始給首位患者注射藥劑。 Athenex的醫療長Rudolf...
Athenex, Inc. Announces Commencement of Patient Enrollment for Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer
July 19, 2017 08:00 ET | Athenex, Inc.
BUFFALO, N.Y., July 19, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex藥劑部獲得FDA許可證,可進口8.4%碳酸氫鈉注射液,解決美國藥品短缺
July 13, 2017 07:15 ET | Athenex, Inc.
紐約州水牛城, July 13, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc.(NASDAQ:ATNX)是一間全球性的生物醫藥公司,致力於發掘、研發及商業化新型療法以治療癌症。今日,Athenex,...
Athenex Pharmaceutical Division Receives FDA Clearance to Import Sodium Bicarbonate 8.4% Injection to Address U.S. Drug Shortage
July 12, 2017 09:00 ET | Athenex, Inc.
BUFFALO, N.Y., July 12, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for...
Athenex, Inc.宣布向中國藥監局提出Oraxol的新藥臨床試驗申請
July 05, 2017 18:25 ET | Athenex, Inc.
紐約州水牛城, July 06, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc.(Nasdaq:...